S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

KROS Keros Therapeutics Inc

11.65

-0.28 (-2.35%)

Mar 07 2025 - Closed

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Keros Therapeutics (NASDAQ:KROS)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Keros Therapeutics Charts.

Keros Therapeutics (NASDAQ:KROS)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Keros Therapeutics Charts.

Keros Therapeutics Inc News

Form 8-K - Current report
Thursday 6 March 2025 (3 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 28 February 2025 (1 week ago) • Edgar (US Regulatory)

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
Friday 28 February 2025 (1 week ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 26 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 26 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 26 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
Wednesday 26 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 30 January 2025 (1 month ago) • Edgar (US Regulatory)

Keros Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference
Thursday 30 January 2025 (1 month ago) • GlobeNewswire Inc.

More Keros Therapeutics Inc News Articles

Cann American (CE)

Kraig Biocraft Laborator... (QB)

Asia Broadband (PK)

Digital Brand Media and ... (PK)

Northwest Biotherapeutics (QB)

Lightwave Logic

Intergrated Cannabis Sol... (PK)

Good Vibrations Shoes (PK)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions